Center for Global Development, Washington, DC, USA.
Int J Health Policy Manag. 2023;12:7502. doi: 10.34172/ijhpm.2022.7502. Epub 2022 Aug 31.
As countries around the world seek to deliver universal health coverage, they must prioritize which services to pay for with public funds, to whom, and at what cost. Countries are increasingly using health technology assessment (HTA) to identify which interventions provide the best value for money and merit inclusion in their health benefit packages (HBPs)-the explicit lists of health services provided using public funds. Oortwijn et al understand the importance of providing practical guidance on the foundation of HBP design, and their article, "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide," provides recommendations for HTA bodies to improve the legitimacy of their decision-making by incorporating four elements in their HBP procedures: stakeholder involvement, evidence-informed evaluation, transparency, and appeal. This article proposes three approaches to enhance the value of the guide: moving from structure to compliance and performance, prioritizing key issues of legitimacy within HBP processes, and acknowledging potential the costs and risks associated with the use of this framework.
随着世界各国寻求实现全民健康覆盖,它们必须优先考虑用公共资金为哪些服务提供资金、提供给谁以及成本是多少。各国越来越多地使用卫生技术评估(HTA)来确定哪些干预措施具有最佳的成本效益,值得纳入其健康福利包(HBPs)——即使用公共资金提供的明确卫生服务清单。Oortwijn 等人认识到就 HBP 设计基础提供实用指导的重要性,他们的文章“健康福利包设计的循证审议过程 - 第二部分:实用指南”为 HTA 机构提供了建议,即通过在其 HBP 程序中纳入四个要素,来提高其决策的合法性:利益相关者参与、基于证据的评估、透明度和申诉。本文提出了三种方法来增强该指南的价值:从结构转向合规和绩效、优先考虑 HBP 流程中与合法性相关的关键问题、以及承认使用该框架相关的潜在成本和风险。